- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07944404
Prophylactic Phasix™ Mesh for Incisional Hernia Prevention in IBD Surgery: A Prospective Multicenter Study (ProPhIS)
Assessing the Incidence of Incisional Hernia Rates in Inflammatory Bowel Disease Patients Undergoing Open or Minimally Invasive Abdominal Surgery With Use of Prophylactic Phasix™ Mesh Reinforcement: A Multicenter, Single-Arm, Two Strata Prospective Study.
The goal of this clinical trial is to evaluate the incidence of incisional hernia, detected by ultrasound imaging, two years after surgery in patients with Inflammatory Bowel Disease (IBD) undergoing either open or minimally invasive abdominal surgery with the use of prophylactic Phasix™ Mesh reinforcement. The study focuses on consecutive adult patients aged 18 years or older with a confirmed histological diagnosis of Crohn's disease or Ulcerative Colitis who are scheduled for elective abdominal surgery, specifically minimally invasive surgery requiring a periumbilical incision for specimen extraction or open abdominal surgery via a midline incision for patients undergoing their second or subsequent abdominal operation for IBD. The main questions it aims to answer are: what is the rate of 24-month incisional hernia as diagnosed by ultrasound imaging in the prospective study population, and how do secondary outcomes such as postoperative pain, quality of life, surgical site occurrences, and 90-day complication rates compare across these surgical strata? If there is a comparison group: Researchers will compare participants who received open surgery to those who received minimally invasive surgery to see if there are significant differences in the 24-month incisional hernia rates, complication profiles, and recovery metrics. Participants will undergo their planned abdominal surgery according to standard institutional care pathways, during which the study device-the Phasix™ Mesh-will be positioned to reinforce either the periumbilical extraction site in minimally invasive procedures or the midline incision in open surgeries using a standardized onlay technique. Following surgery, participants will be asked to complete a series of main tasks and evaluations, which include providing daily self-reported pain ratings on a Visual Analog Scale during hospitalization, attending scheduled follow-up visits at 30 days, 6 months, 12 months, and 24 months post-surgery, undergoing clinical evaluations and wound inspections with standardized photographic documentation at each visit, completing validated questionnaires including the Short-Form Health Survey-36, Ventral Hernia Pain Questionnaire, and Carolinas Comfort Scale at specified postoperative time points, and undergoing delegated ultrasound imaging of the entire length of the incision in both supine resting and dynamic states during the 12-month and 24-month follow-up visits to detect any occult or overt fascial defects or herniation.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Matteo Rottoli, MD
- Telefoonnummer: +39 0512144807
- E-mail: matteo.rottoli@unibo.it
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
Adult patients aged ≥ 18 years at the time of screening.
-
Confirmed (histologically proven) diagnosis of Crohn's disease or Ulcerative Colitis.
-
Scheduled to undergo abdominal surgery, specifically:
- Minimally invasive surgery (laparoscopic or robotic) requiring a periumbilicaln incision for specimen extraction.
- Open abdominal surgery (laparotomy) via a midline incision, for patients undergoing their second or subsequent abdominal operation for IBD.
-
Willingness and ability to provide informed consent.
-
Willingness and ability to comply with follow-up requirements, including ultrasound examinations.
Exclusion Criteria:
- Emergency surgery (e.g., for perforation with gross contamination, hemodynamic instability requiring immediate life-saving surgery without time for prophylactic mesh consideration).
- Presence of an existing incisional hernia at the planned incision site.
- Known allergy or hypersensitivity to any components of Phasix™ Mesh. In particular, known allergy to tetracycline hydrochloride or kanamycin sulfate.
- Current gross abdominal sepsis or infection that, in the surgeon's judgment, would contraindicate mesh placement.
- Life expectancy less than two years.
- Pregnant or breastfeeding women.
- Participation in another interventional trial that might confound the study results.
- Previous mesh placement at the index incision site (for open surgery patients)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: MIS with Phasix Mesh Reinforcement
Patients with Inflammatory Bowel Disease undergoing elective minimally invasive (laparoscopic or robotic) abdominal surgery who receive prophylactic Phasix Mesh reinforcement of the periumbilical specimen extraction site using a standardized technique. |
A fully resorbable monofilament scaffold (Phasix Mesh) placed during elective abdominal surgery to reinforce either the periumbilical specimen extraction site in minimally invasive surgery or the midline incision in open surgery, using a standardized onlay technique. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
the rate of 24-month incisional hernia
Tijdsspanne: baseline
|
diagnosed by ultrasound imaging |
baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
rate of 12-month incisional hernia
Tijdsspanne: baseline
|
baseline
|
|
median value of the participants-reported pain
Tijdsspanne: study visits after surgey
|
study visits after surgey
|
|
The median value of the Ventral Hernia Pain Questionnaire (VHPQ)
Tijdsspanne: after surgery
|
after surgery
|
|
The median value of the Short-Form Health Survey-36 (SF-36)
Tijdsspanne: after surgery
|
after surgery
|
|
The median value of the Carolinas Comfort Scale (CCS)
Tijdsspanne: after surgery
|
after surgery
|
|
The median difference in the 24-month VAS scores
Tijdsspanne: 24 month after surgery
|
24 month after surgery
|
|
The rate of 90-day postoperative complications classified according to the Clavien-Dindo scale
Tijdsspanne: 90 after surgery
|
90 after surgery
|
|
The rate of 90-day reoperations
Tijdsspanne: 90 after surgery
|
90 after surgery
|
|
The rate of 24-month incisional hernia between the participants who received open surgery and those who received MIS.
Tijdsspanne: 24 months after surgery
|
24 months after surgery
|
|
The median difference in the 24-month VHPQ scores
Tijdsspanne: 24 months after surgery
|
24 months after surgery
|
|
The median difference in the 24-month SF-36 scores
Tijdsspanne: 24 months after surgery
|
24 months after surgery
|
|
The median difference in the 24-month CCS scores
Tijdsspanne: 24 months after surgery
|
24 months after surgery
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- ProPhIS
- CyberGrant 103751599 (Ander subsidie-/financieringsnummer: Becton Dickinson Holdings Pte Ltd)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .